The latest round of FDA warning letters to food manufacturers, who are stepping over the line between marketing claims and health claims, provides a ringside seat into the daily judgment calls that communicators are often asked to weigh in on — if they know about them.

Sixteen food manufacturers received warning letters from the Food and Drug Administration (FDA) this week for making misleading health claims on food packaging.

"Don't let what you cannot do interfere with what you can do." (RED) continues to build momentum on the basis of this insight from John Wooden, legendary UCLA basketball coach.

The Food & Drug Administration (FDA) held public hearings in mid-November with industry leaders to gather information about using social media and the Web to promote FDA-regulated medical products.

Last week, for the first time in more than a decade, the US Food and Drug Administration convened a hearing on the promotion of FDA-regulated medical products via online channels, including the latest online phenomenon: social media.

The dramatic patient story - from the face-transplant patient on a recent 'Oprah Winfrey Show' to the first child implanted with an artificial heart - is at the core of healthcare PR. But is this well-loved approach becoming jaded?

In the midst of the contentious healthcare debate raging on Capitol Hill, not to mention lingering decisions about the way forward in Afghanistan and the recent depressing news that the US domestic jobless rate passed the 10% mark, President Barack Obama will travel through Asia.

Players in a year-long debate on healthcare reform are united in at least one respect.

Anyone who has worked on a campaign tied to charity, or another message of giving, will likely tell you that it was by far their most rewarding and enjoyable challenge.

The old axiom that it takes a lifetime to build a good reputation and only minutes to destroy it has never seemed truer.